A Post-marketing Surveillance Study of Beyfortus (Nirsevimab) in Republic of Korea — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Post-marketing Surveillance Study of Beyfortus (Nirsevimab) in Republic of Korea — Stella

Recruiting

Back to Respiratory Syncytial Virus trials

Trial locations(1 site)

South Korea

Nam Seung Woo Pediatric: 4100007, Hwaseong-si, Gyeonggi-do

Key details

Sponsor

Sanofi

Enrollment target

~3,000 participants

Started

October 2025

Primary completion

September 2029

Age range

0 Days – 24 Months

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov